250 related articles for article (PubMed ID: 9342558)
1. Current and emerging treatments for pancreatic cancer.
Regine WF; John WJ; Mohiuddin M
Drugs Aging; 1997 Oct; 11(4):285-95. PubMed ID: 9342558
[TBL] [Abstract][Full Text] [Related]
2. Evolving trends in combined modality therapy for pancreatic cancer.
Regine WF; John WJ; Mohiuddin M
J Hepatobiliary Pancreat Surg; 1998; 5(3):227-34. PubMed ID: 9880768
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant therapy for pancreatic cancer: current status.
Regine WF; John WJ; Mohiuddin M
Front Biosci; 1998 Nov; 3():E186-92. PubMed ID: 9820740
[TBL] [Abstract][Full Text] [Related]
4. A phase II study of alternating cycles of split course radiation therapy and gemcitabine chemotherapy for inoperable pancreatic or biliary tract carcinoma.
Lin LL; Picus J; Drebin JA; Linehan DC; Solis J; Strasberg SM; Tan B; Thorstad WL; Myerson R
Am J Clin Oncol; 2005 Jun; 28(3):234-41. PubMed ID: 15923794
[TBL] [Abstract][Full Text] [Related]
5. [Radiotherapeutic strategies in the multimodal therapy of resectable and nonresectable pancreatic carcinoma].
Wiegel T; Runkel N; Frommhold H; RĂ¼be C; Hinkelbein W
Strahlenther Onkol; 2000 Jul; 176(7):299-306. PubMed ID: 10962995
[TBL] [Abstract][Full Text] [Related]
6. Postoperative gemcitabine alone and concurrent with radiation therapy in locally advanced pancreatic carcinoma.
Ozkok S; Demirci S; Yalman D; Zeytunlu M; Nart D; Yuzer Y; Coker A; Goker E
Tumori; 2010; 96(4):560-7. PubMed ID: 20968135
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and efficacy of combination therapy with preoperative full-dose gemcitabine, concurrent three-dimensional conformal radiation, surgery, and postoperative liver perfusion chemotherapy for T3-pancreatic cancer.
Ohigashi H; Ishikawa O; Eguchi H; Takahashi H; Gotoh K; Yamada T; Yano M; Nakaizumi A; Uehara H; Tomita Y; Nishiyama K
Ann Surg; 2009 Jul; 250(1):88-95. PubMed ID: 19561477
[TBL] [Abstract][Full Text] [Related]
8. Current status of adjuvant therapy for pancreatic cancer.
Katz MH; Fleming JB; Lee JE; Pisters PW
Oncologist; 2010; 15(11):1205-13. PubMed ID: 21045189
[TBL] [Abstract][Full Text] [Related]
9. Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II study.
Van Laethem JL; Demols A; Gay F; Closon MT; Collette M; Polus M; Houbiers G; Gastelblum P; Gelin M; Houtte PV; Closset J
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):974-80. PubMed ID: 12829132
[TBL] [Abstract][Full Text] [Related]
10. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.
Regine WF; Winter KA; Abrams RA; Safran H; Hoffman JP; Konski A; Benson AB; Macdonald JS; Kudrimoti MR; Fromm ML; Haddock MG; Schaefer P; Willett CG; Rich TA
JAMA; 2008 Mar; 299(9):1019-26. PubMed ID: 18319412
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant therapy in pancreatic cancer: a critical appraisal.
Oettle H; Neuhaus P
Drugs; 2007; 67(16):2293-310. PubMed ID: 17983252
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of multimodal treatment for patients with resectable carcinoma of the pancreas.
Okabayashi T; Nishimori I; Nishioka A; Yamashita K; Sugimoto T; Dabanaka K; Maeda H; Kohsaki T; Ogawa Y; Kobayashi M; Onishi S; Hanazaki K
Oncol Rep; 2008 Sep; 20(3):651-6. PubMed ID: 18695919
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant therapy for pancreatic cancer: back to the future.
Regine WF; Abrams RA
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):59-63. PubMed ID: 9747820
[TBL] [Abstract][Full Text] [Related]
14. Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
Crane CH; Abbruzzese JL; Evans DB; Wolff RA; Ballo MT; Delclos M; Milas L; Mason K; Charnsangavej C; Pisters PW; Lee JE; Lenzi R; Vauthey JN; Wong AB; Phan T; Nguyen Q; Janjan NA
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1293-302. PubMed ID: 11955742
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration.
Breslin TM; Hess KR; Harbison DB; Jean ME; Cleary KR; Dackiw AP; Wolff RA; Abbruzzese JL; Janjan NA; Crane CH; Vauthey JN; Lee JE; Pisters PW; Evans DB
Ann Surg Oncol; 2001 Mar; 8(2):123-32. PubMed ID: 11258776
[TBL] [Abstract][Full Text] [Related]
16. Future chemoradiation strategies in pancreatic cancer.
Crane CH; Varadhachary G; Pisters PW; Evans DB; Wolff RA
Semin Oncol; 2007 Aug; 34(4):335-46. PubMed ID: 17674962
[TBL] [Abstract][Full Text] [Related]
17. Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma.
Pisters PW; Abbruzzese JL; Janjan NA; Cleary KR; Charnsangavej C; Goswitz MS; Rich TA; Raijman I; Wolff RA; Lenzi R; Lee JE; Evans DB
J Clin Oncol; 1998 Dec; 16(12):3843-50. PubMed ID: 9850029
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant strategies for pancreatic cancer.
Evans DB; Wolff RA; Crane CH
Oncology (Williston Park); 2001 Jun; 15(6):727-37; discussion 741-4, 747. PubMed ID: 11430206
[TBL] [Abstract][Full Text] [Related]
19. Curative radiation therapy for pancreatic malignancies.
Cooke EW; Hazard L
Surg Clin North Am; 2010 Apr; 90(2):341-54. PubMed ID: 20362790
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy for carcinoma of the pancreas.
Thomas PR
Semin Oncol; 1996 Apr; 23(2):213-9. PubMed ID: 8623057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]